{"id":303093,"date":"2015-02-17T17:00:00","date_gmt":"2015-02-17T22:00:00","guid":{"rendered":"https:\/\/www.investmentexecutive.com\/uncategorized\/ssq-to-introduce-comprehensive-critical-illness-coverage\/"},"modified":"2015-02-17T17:00:00","modified_gmt":"2015-02-17T22:00:00","slug":"ssq-to-introduce-comprehensive-critical-illness-coverage","status":"publish","type":"post","link":"https:\/\/www.investmentexecutive.com\/news\/products\/ssq-to-introduce-comprehensive-critical-illness-coverage\/","title":{"rendered":"SSQ to introduce comprehensive critical illness coverage"},"content":{"rendered":"<p> Quebec City-based group insurance firm SSQ Financial Group is set to launch an exclusive new critical illness insurance product in March.<\/p>\n<p> The new product will feature three separate coverage options: basic (6 illnesses), complete (24 illnesses), and Total (40 illnesses). This makes it the most generous, comprehensive, and flexible group insurance product available in Canada, SSQ says.<\/p>\n<p> SSQ says it will be the only insurer in Canada to cover auto-immune diseases and 40 critical illnesses, in addition to requiring a survival period of just 14 days.<\/p>\n<p> &#8220;SSQ Financial Group&#8217;s critical illness insurance lineup is a testament to our core values and commitment to developing products tailored to the needs and realities of today&#8217;s consumer,&#8221; says Carl Laflamme, senior vice president of group Insurance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Group insurer says it will cover auto-immune diseases and 40 critical illnesses<\/p>\n","protected":false},"author":38954,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2312,2315],"tags":[2605,2603],"yst_prominent_words":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/posts\/303093"}],"collection":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/users\/38954"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/comments?post=303093"}],"version-history":[{"count":0,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/posts\/303093\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/media?parent=303093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/categories?post=303093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/tags?post=303093"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/yst_prominent_words?post=303093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}